Finance

Lists
LUPIN:NSE
Lupin Ltd
1 982,20 INR
+1,48%
(+29,00) 1D
15-окт., 10:33:40 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LUPIN...
Open
1 943,00 INR
High
1 984,00 INR
Low
1 943,00 INR
Mkt. cap
906,44 млд
Avg. vol.
706,56 миң
Volume
173,54 миң
Dividend
0,91%
Quarterly dividend
4,50 INR
Ex-dividend date
2026-ж., 17-июл.
P/E ratio
15,49
52-wk high
2 529,50 INR
52-wk low
1 900,00 INR
EPS
127,94 INR
Shares outstanding
452,41 млн
No. of employees
26 миң
Open
1 943,00 INR
High
1 984,00 INR
Low
1 943,00 INR
Mkt. cap
906,44 млд
Avg. vol.
706,56 миң
Volume
173,54 миң
Dividend
0,91%
Quarterly dividend
4,50 INR
Ex-dividend date
2026-ж., 17-июл.
P/E ratio
15,49
52-wk high
2 529,50 INR
52-wk low
1 900,00 INR
EPS
127,94 INR
Shares outstanding
452,41 млн
No. of employees
26 миң
News stories
From web sources and news partners
Profile
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.The company operates in multiple international markets including the United States, Japan, Europe, and Australia.. Wikipedia
About Lupin Ltd
CEOVinita D. Gupta
Employees26 миң
Founded1968
HeadquartersМамбай, Махараштра, Индия
SectorPharmaceutical industry
Websitelupin.com
Last report
2026-ж., 7-авг.
Fiscal period
Q1 2027
30,89 INR / 28,89 INR
+6,93%beat
Revenue / Est. (INR)
82,77 млд / 79,18 млд
+4,53%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
70,48 млд
71,68 млд
74,75 млд
82,77 млд
Cost of goods sold
18,25 млд
18,78 млд
24,90 млд
20,89 млд
Cost of revenue
18,25 млд
18,78 млд
24,90 млд
20,89 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,06 млд
11,43 млд
13,85 млд
13,83 млд
Operating expense
34,02 млд
33,93 млд
31,74 млд
40,89 млд
Total operating expenses
52,27 млд
52,71 млд
56,64 млд
61,78 млд
Operating income
18,21 млд
18,97 млд
18,10 млд
20,99 млд
Other non operating income
900,00 млн
1,15 млд
-2,87 млд
1,30 млд
EBT including unusual items
20,07 млд
15,22 млд
19,28 млд
20,17 млд
EBT excluding unusual items
20,07 млд
19,49 млд
19,91 млд
21,05 млд
Income tax expense
5,22 млд
3,42 млд
4,59 млд
6,00 млд
Effective tax rate
26,02%
22,44%
23,82%
29,76%
Other operating expenses
19,80 млд
19,37 млд
14,55 млд
23,41 млд
Net income
14,78 млд
11,76 млд
14,60 млд
14,15 млд
Net profit margin
20,97%
16,40%
19,54%
17,10%
Earnings per share
32,28
32,18
34,75
30,89
Interest and investment income
-
-
2,17 млд
-
Interest expense
-1,08 млд
-1,15 млд
-633,10 млн
-1,10 млд
Net interest expenses
-1,08 млд
-1,15 млд
1,54 млд
-1,10 млд
Depreciation and amortization charges
3,17 млд
3,13 млд
3,34 млд
3,65 млд
EBITDA
21,29 млд
21,20 млд
20,81 млд
23,69 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору